BCR-ABL1-mediated activation of JAK2 and STAT5 in both CML and Ph-positive B-ALL can sustain elevated MYC levels through promoting its gene expression and guarding MYC against ubiquitination and proteasome-dependent degradation (Fig. 7) [454, 455]. Here, MYC is linked to acute lymphoblastic leukemia.